Genetic Technologies Acquires EasyDNA from BelHealth

Genetic Technologies Acquires AffinityDNA Direct-to-Consumer Business

July 14, 2022

Biotechnology

Genetic Technologies Limited (GENE) completed the acquisition of the direct-to-consumer eCommerce business and distribution rights of AffinityDNA, including websites, brand identities, laboratory testing and distribution agreements. The deal expands GENE’s direct-to-consumer channel and product portfolio across the US, UK and Europe, adding AffinityDNA’s consumer and pet genomics offerings to GENE’s geneType and EasyDNA brands.

Eurobio Scientific Acquires GenDx (Genome Diagnostics B.V.)

October 4, 2022

Biotechnology

Paris-based Eurobio Scientific has acquired all outstanding shares of Dutch transplant diagnostics specialist GenDx (Genome Diagnostics B.V.), following a share purchase agreement signed on August 17. The acquisition expands Eurobio's molecular diagnostics portfolio in transplantation and secures the company legacy with proceeds funding a GenDx foundation established by the founders.

Eurofins Acquires DNA Diagnostics Center from GHO Capital

June 28, 2021

Healthcare Services

Eurofins, the publicly traded global laboratory testing group, has agreed to acquire DNA Diagnostics Center (DDC), a consumer-focused DNA testing company based in Fairfield, Ohio, from GHO Capital. DDC, which has approximately 240 employees and a broad portfolio of at‑home and lab-based DNA tests, will join Eurofins to expand its consumer genetics and health & wellness testing capabilities and global reach.

Dotmatics Acquires SoftGenetics to Expand Genetic Analysis Capabilities

June 12, 2023

Software

Dotmatics has acquired SoftGenetics, a bioinformatics software company that provides genetic analysis tools for research, clinical, and forensic applications. The acquisition expands Dotmatics' R&D scientific software portfolio by adding SoftGenetics' suite of sequencing and genotyping products while allowing SoftGenetics to operate as a standalone business within Dotmatics.

GeneDx Acquires Fabric Genomics

May 7, 2025

Healthcare Services

GeneDx (Nasdaq: WGS) has completed its acquisition of Fabric Genomics, an Oakland-based developer of AI-powered genomic interpretation software. Fabric will operate as a wholly owned subsidiary of GeneDx, enabling integrated centralized and decentralized genomic testing, accelerating NICU genomic testing and newborn screening programs, and unlocking recurring software-based revenue streams.

Novacyt Acquires Yourgene Health plc

September 8, 2023

Medical Devices

Novacyt, through its wholly-owned subsidiary Novacyt UK Holdings Limited, has completed the acquisition of Yourgene Health plc by way of a court-sanctioned scheme of arrangement. The deal brings together Novacyt's diagnostics capabilities with Yourgene's genomic technologies and services to create a larger, diversified international molecular diagnostics business headquartered in Manchester, UK.